Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
5.73
-0.36 (-5.91%)
At close: Jun 5, 2026, 4:00 PM EDT
5.83
+0.10 (1.75%)
Pre-market: Jun 8, 2026, 7:55 AM EDT
Wave Life Sciences Revenue
Wave Life Sciences had revenue of $38.25M in the quarter ending March 31, 2026, with 316.85% growth. This brings the company's revenue in the last twelve months to $71.80M, down -31.58% year-over-year. In the year 2025, Wave Life Sciences had annual revenue of $42.73M, down -60.55%.
Revenue (ttm)
$71.80M
Revenue Growth
-31.58%
P/S Ratio
15.36
Revenue / Employee
$226,492
Employees
317
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.73M | -65.58M | -60.55% |
| Dec 31, 2024 | 108.30M | -5.00M | -4.42% |
| Dec 31, 2023 | 113.31M | 109.66M | 3,005.10% |
| Dec 31, 2022 | 3.65M | -37.32M | -91.09% |
| Dec 31, 2021 | 40.96M | 20.89M | 104.03% |
| Dec 31, 2020 | 20.08M | 4.09M | 25.61% |
| Dec 31, 2019 | 15.98M | 1.57M | 10.89% |
| Dec 31, 2018 | 14.41M | 10.52M | 270.25% |
| Dec 31, 2017 | 3.89M | 2.80M | 256.50% |
| Dec 31, 2016 | 1.09M | 940.00K | 618.42% |
| Dec 31, 2015 | 152.00K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MannKind | 360.78M |
| Precigen | 31.60M |
| Zenas BioPharma | 10.00M |
| Aktis Oncology | 8.28M |
| EyePoint | 7.61M |
| DBV Technologies | 5.74M |
| Absci | 1.84M |
WVE News
- 4 days ago - Wave Life Sciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 days ago - Wave Life Sciences to Present at Upcoming Investor Conferences - GlobeNewsWire
- 11 days ago - Wave Life Sciences Ltd. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses - GlobeNewsWire
- 19 days ago - Wave Life Sciences Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Wave Life Sciences price target raised to $14 from $13 at Wells Fargo - TheFly
- 19 days ago - Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 - PRNewsWire
- 20 days ago - Wave Life Sciences price target lowered to $13 from $18 at H.C. Wainwright - TheFly
- 20 days ago - Wave Life Sciences Transcript: Study update - Transcripts